Tuberculosis and HIV co-infection in European Union and European Economic Area countries

L. Pimpin, L. N. Drumright, M. E. Kruijshaar, I. Abubakar, B. Rice, V. Delpech, V. Hollo, A. Amato-Gauci, D. Manissero, C. Kodmon

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)


In order to ensure the availability of resources for tuberculosis (TB) and HIV management and control, it is imperative that countries monitor and plan for co-infection in order to identify, treat and prevent TB-HIV co-infection, thereby reducing TB burden and increasing the years of healthy life of people living with HIV. A systematic review was undertaken to determine the burden of TB-HIV infection in the European Union (EU) and European Economic Area (EEA). Data on the burden of HIV infection in TB patients and risk factors for TB-HIV co-infection in the EU/EEA were extracted from studies that collected information in 1996 and later, regardless of the year of initiation of data collection, and a narrative synthesis presented. The proportion of HIV-co-infected TB patients varied from 0 to 15%. Western and eastern countries had higher levels and increasing trends of infection over time compared with central EU/EEA countries. Groups at higher risk of TB-HIV co-infection were males, young adults, foreign-born persons, the homeless, injecting drug users and prisoners. Further research is needed into the burden and associated risk factors of co-infection in Europe, to help plan effective control measures. Increased HIV testing of TB patients and targeted and informed strategies for control and prevention could help curb the co-infection epidemic.
Original languageEnglish
Pages (from-to)1382-1392
Number of pages11
JournalEuropean Respiratory Journal
Issue number6
Publication statusPublished - Dec 2011

Cite this